NCT00832520 Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight Status TERMINATED Phase PHASE2
NCT00798252 Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers Status COMPLETED Phase PHASE1
NCT00792896 Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease Status UNKNOWN Phase NA
NCT00785226 RDEA119 and Sorafenib Combination Dose Escalation Study Status COMPLETED Phase PHASE1/PHASE2
NCT00761618 Intrapleural Catheter Daily Versus Three Times a Week Drainage Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00741403 A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00736372 A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00729833 Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00710736 A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00708773 Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00698841 Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors Status COMPLETED Phase PHASE2
NCT00697632 Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00688038 Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy Status COMPLETED Phase PHASE4